This newsletter provides information on recent literature in breast cancer and other oncology fields, upcoming conferences, and a discussion forum for specialists. It includes summaries of 10 recent papers on topics like triple negative breast cancer treatment and outcomes of tamoxifen therapy. The editor announces a new online community for specialists called Senology.org - International Senologic and Oncologic Scientific Community within Doctorsbook.com.
The LANCET Oncology is the world-leading clinical oncology research journal globally (2021 Journal Citation Reports®, Clarivate 2022) With an Impact Factor of 54·433.
Publisher: Elsevier's Oncology Journal Network
Total Indexing – 11
Some Indexing sites are – Scopus , MEDLINE ,PubMed , Chemical Abstracts , Essential Science Indicators ,etc .
Editor :David Collingridge, Editor-in-Chief , gained a PhD in Tumour Biology from the Gray Cancer Institute/University College London (UK) and held research posts in the Department of Therapeutic Radiology, Yale University (USA) and in the PET Oncology Group, Imperial College School of Medicine, Hammersmith Hospital (UK)
How to have quality of life in Advanced ovarian malignancyRajesh Gajbhiye
Presentation given by Dr Rakhi Gajbhiye, Mauli Hospital Nagpur at MGIMS sewagram for an International conference on Womens Health Fatal Disorders Survival with Quality in collaboration with FOGSI.
This was the function to commemorate 100 th birth centenary of Dr Sushila
Invasive Lobular Carcinoma — Highlights from the First Ever ILC Symposium bkling
Steffi Osterreich, PhD, and Rachel Jankowitz, MD, of University of Pittsburgh Cancer Institute, join Heather Hillier, breast advocate and co-chair of the first international ILC Symposium, in offering an overview of Invasive Lobular Carcinoma and highlights from the conference, which took place in Pittsburgh in September 2016. The program was presented in collaboration with MBCN.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
1. Senology Newsletter file:///C:/Documents and Settings/utente/Desktop/Newsl_Apr2011.htm
Senology.org - Newsletter
International Senologic and Oncologic Scientific Community
"Connecting specialists worldwide"
Editor-in-chief: Gian Paolo Andreoletti, MD
Subscribe Unsubscribe Contact Back Issues
Connecting Specialists Worldwide
Join us on Facebook®, Twitter®, YouTube®, LinkedIn® and Doctorsbook® and share informations, opinions
and suggestions. Follow our RSS feeds
Literature Selection
Geffen DB et al.: "The impact of the 21-gene recurrence score assay on decision making about
adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology
practice with a unified treatment policy", Ann Oncol. 2011 Mar 1. [Epub ahead of print]
Blixt O et al.: "Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are
associated with a better prognosis", Breast Cancer Res. 2011 Mar 8;13(2):R25. [Epub ahead of print]
Luo J et al.: "Association of active and passive smoking with risk of breast cancer among
postmenopausal women: a prospective cohort study", BMJ. 2011 Mar 1;342:d1016. doi:
10.1136/bmj.d1016
Rosato V et al.: "Metabolic syndrome and the risk of breast cancer in postmenopausal women", Ann
Oncol. 2011 Mar 17. [Epub ahead of print]
Kalinyak JE et al.: "PET-Guided Breast Biopsy", Breast J. 2011 Mar;17(2):143-51
Keam B et al.: "Ki-67 can be used for further classification of triple negative breast cancer into two
subtypes with different response and prognosis", Breast Cancer Res. 2011 Mar 2;13(2):R22. [Epub
ahead of print]
Conklin MW et al.: "Aligned collagen is a prognostic signature for survival in human breast
carcinoma", Am J Pathol. 2011 Mar;178(3):1221-32
Fakkert IE et al.: "Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk
reducing salpingo-oophorectomy", Breast Cancer Res Treat. 2011 Mar 4. [Epub ahead of print]
Hackshaw A et al.: "Long-Term Benefits of 5 Years of Tamoxifen: 10-Year Follow-Up of a Large
Randomized Trial in Women at Least 50 Years of Age With Early Breast Cancer", J Clin Oncol. 2011
Mar 21. [Epub ahead of print]
Noah Vanhoucke J et al.: "Cost-effectiveness of chemoprevention of breast cancer using tamoxifen
in a postmenopausal US population", Cancer. 2011 Mar 14. doi: 10.1002/cncr.25926. [Epub ahead of
print]
1 di 3 05/04/2011 15:33
2. Senology Newsletter file:///C:/Documents and Settings/utente/Desktop/Newsl_Apr2011.htm
Goyal S et al.: "Ductal carcinoma in situ treated with breast-conserving surgery and accelerated
partial breast irradiation: Comparison of the Mammosite registry trial with intergroup study E5194",
Cancer. 2011 Mar 15;117(6):1149-55
Comment
"Strategies for the management of triple negative breast cancer", Hiroshi Yagata, Department of
Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan
"Triple negative breast cancer (TNBC) is a minor subtype and has distinctive aspect of clinical behavior.
TNBC often shows rapid and expanding growth pattern, unlike luminal type. Chemotherapy is the only
method as systemic therapy and shows remarkable effect with relatively high probability; to the contrary,
some of TNBCs show overt progression in a short period during chemotherapy and develop early recurrence
with short survival. Various molecular targeting therapies are developing, but do not reach our daily practice.
So we tried to explore effective ways of treatment for TNBC from both previous reports and our experiences
in the literature. We need to consider effective treatment strategy for TNBC, including local therapy as well
as systemic therapy with special care"
(Comment on: Yagata H et al.: "Current strategy for triple-negative breast cancer: appropriate
combination of surgery, radiation, and chemotherapy", Breast Cancer. 2011 Feb 3. [Epub ahead of
print])
Calendar of Events
Gene profiling in Clinical Oncology, Viareggio, Italy, April 8-9, 2011
IMPAKT Breast Cancer Conference, May 5-7, 2011, Brussels, Belgium
12th Greek National Congress of Mastology with international participation, May 6-8, 2011, Kalamata,
Greece
6th World Conference on Breast Cancer, June 7 -11, 2011, Hamilton, Ontario, Canada
13th Milan Breast Cancer Conference, June 22-24, 2011, Milan Italy
AORTIC (African Organisation for Research and Training in Cancer) - 8th International Conference,
November 28 - December 2, 2011, Cairo, Egypt
Literature Selection
Hsiao W et al.: "Successful Treatment of Postchemotherapy Azoospermia With Microsurgical
Testicular Sperm Extraction: The Weill Cornell Experience", J Clin Oncol. 2011 Mar 14. [Epub ahead
of print]
Chamie K et al.: "Secondary malignancies among nonseminomatous germ cell tumor cancer
survivors", Cancer. 2011 Mar 15. doi: 10.1002/cncr.26038. [Epub ahead of print]
Kim HS et al.: "A natural history of weight change in men with prostate cancer on androgen-
deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital
(SEARCH) database", BJU Int. 2011 Mar;107(6):924-928
Kollmeier MA et al.: "Improved biochemical outcomes with statin use in patients with high-risk
localized prostate cancer treated with radiotherapy", Int J Radiat Oncol Biol Phys. 2011 Mar
1;79(3):713-8
Lu L et al.: "Long-term overweight and weight gain in early adulthood in association with risk of
endometrial cancer", Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26046. [Epub ahead of print]
Green DM et al.: "Decreased fertility among female childhood cancer survivors who received 22-27
Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study", Fertil
Steril. 2011 Mar 2. [Epub ahead of print]
Chan AT et al.: "Inflammatory markers are associated with risk of colorectal cancer and
chemopreventive response to anti-inflammatory drugs", Gastroenterology. 2011
Mar;140(3):799-808.e2
van Hooft JE et al.: "Colonic stenting versus emergency surgery for acute left-sided malignant
colonic obstruction: a multicentre randomised trial", Lancet Oncol. 2011 Mar 11. [Epub ahead of
print]
Pickhardt PJ et al.: "Colorectal Cancer: CT Colonography and Colonoscopy for Detection--
Systematic Review and Meta-Analysis", Radiology. 2011 Mar 17. [Epub ahead of print]
Kang SY et al.: "Helicobacter pylori infection as an independent prognostic factor for locally
advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection", Int J
2 di 3 05/04/2011 15:33
3. Senology Newsletter file:///C:/Documents and Settings/utente/Desktop/Newsl_Apr2011.htm
Cancer. 2011 Mar 21. doi: 10.1002/ijc.26081. [Epub ahead of print]
Gapstur SM et al.: "Association of alcohol intake with pancreatic cancer mortality in never smokers",
Arch Intern Med. 2011 Mar 14;171(5):444-51
Koshy M et al.: "Impact of Neoadjuvant Radiation on Survival in Stage III Non-Small-Cell Lung
Cancer", Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1388-94
Guglielmelli T et al.: "Previous thalidomide therapy may not affect lenalidomide response and
outcome in relapse or refractory multiple myeloma patients", Eur J Cancer. 2011 Apr:47(8):414-18
Gambacorti-Passerini C et al.: "Multicenter Independent Assessment of Outcomes in Chronic
Myeloid Leukemia Patients Treated With Imatinib", J Natl Cancer Inst. 2011 Mar 21. [Epub ahead of
print]
Discussions
"What do you think about NICE clinical guideline for colonoscopic surveillance to prevent colorectal
cancer in people with ulcerative colitis, Crohn's disease or adenomas?" - Share your opinion on LinkedIn®
Fragments of History
In the 19th century, the German scientist Rudolf Virchow (1821-1902), often called the "founder of cellular
pathology", provided the scientific basis for the modern cytological research and pathologic study of cancer
Literature Selection
Fife S et al.: "Metoclopramide to augment lactation, does it work? A randomized trial", J Matern Fetal
Neonatal Med. 2011 Mar 17. [Epub ahead of print]
Senology.org opened an on line community (Senology.org - International Senologic and Oncologic Scientific
Community) within the Doctorsbook.com platform, which will allow you to remain in touch and communicate with
colleagues. Join us and receive the weekly oncological Doctorsbook Newsletter!
Stay informed....
Recent Advances in Clinical Medicine
Poordad F et al.: "Boceprevir for untreated chronic HCV genotype 1 infection", N Engl J Med. 2011 Mar
31;364(13):1195-206
Bacon BR et al.: "Boceprevir for previously treated chronic HCV genotype 1 infection", N Engl J Med.
2011 Mar 31;364(13):1207-1
Unsubscribe
www.senology.org
3 di 3 05/04/2011 15:33